Vaccines pushes Pfizer beyond expectations in final quarter
By TOM MURPHY COVID-19 vaccine sales boosted Pfizer earnings well past expectations in the fourth quarter, but the drugmaker is setting a lower-than-expected bar for 2022. Pfizer d…
By TOM MURPHY COVID-19 vaccine sales boosted Pfizer earnings well past expectations in the fourth quarter, but the drugmaker is setting a lower-than-expected bar for 2022. Pfizer d…